Concepedia

Melannie Co

MC

Statistics

Publications

6

Citations

134

H-Index

6

Active since

2014

Affiliations

Concord Repatriation General Hospital(Current)

Monash University

Monash Health

The University of Sydney

The University of Texas MD Anderson Cancer Center

Melannie Co is an author at Concord Repatriation General Hospital specializing in cancer therapeutics, clinical trials, and surgical oncology.

Top concepts

Publications per year

2014–2023

6

Publications

6

A Phase III Study of Zanubrutinib Plus Rituximab Versus Bendamustine Plus Rituximab in Transplant-Ineligible, Untreated Mantle Cell Lymphoma

Martin Dreyling, Constantine S. Tam, Michael Wang et al. · Future Oncology · 2020 · 28 citations · Full text

Safety and efficacy of zanubrutinib in relapsed/refractory marginal zone lymphoma: final analysis of the MAGNOLIA study

Stephen Opat, Alessandra Tedeschi, Bei Hu et al. · Blood Advances · 2023 · 27 citations · Full text

, , +16

The combination of ibrutinib and rituximab demonstrates activity in first‐line follicular lymphoma

Nathan Fowler, Loretta J. Nastoupil, Sven de Vos et al. · British Journal of Haematology · 2020 · 26 citations · Full text

Molecular associations of response to the new-generation BTK inhibitor zanubrutinib in marginal zone lymphoma

Maciej Tatarczuch, Mark Waltham, Jake Shortt et al. · Blood Advances · 2023 · 21 citations · Full text

Efficacy and Safety of Zanubrutinib in Patients with Relapsed/Refractory Marginal Zone Lymphoma: Initial Results of the MAGNOLIA (BGB-3111-214) Trial

Stephen Opat, Alessandra Tedeschi, Kim Linton et al. · Blood · 2020 · 17 citations

1–5 of 6